Form 4: Director Linda Dong Receives Astrana Health Equity Grant
Statement of Changes in Beneficial Ownership
Astrana Health, Inc. director Linda Dong was granted 4,525 restricted shares of common stock vesting in June 2027.
Summary
- Director Linda Dong acquired 4,525 shares of Astrana Health, Inc. (ASTH) common stock.
- The shares were granted as restricted stock under the company's 2024 Equity Incentive Plan.
- The grant has a zero-dollar acquisition price.
- The total beneficial ownership for the director following this transaction is 97,133 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of immediate market impact.
Positives
- Alignment of director interests with shareholders through equity-based compensation.
- Retention incentive for board members via a one-year vesting schedule.
Negatives
- Minor dilution of existing shareholders due to the issuance of new restricted stock.
Risks
- Market volatility affecting the future value of equity-based compensation.
Future Outlook
The restricted shares are scheduled to vest on the earlier of June 10, 2027, or the date of the company's 2027 annual meeting of stockholders.
Industry Context
StockSavvy.ai notes that equity grants to directors are standard corporate governance practices designed to align board incentives with long-term shareholder value, particularly in the healthcare services sector.
Comparison to Industry Standards
- The use of restricted stock units (RSUs) for director compensation is consistent with standard practices among mid-cap healthcare companies.
- The one-year vesting period is a common retention structure for board members in the U.S. public market.
Stakeholder Impact
- Shareholders: Minor dilution impact.
- Director: Increased equity stake in the company.
Next Steps
- Vesting of the 4,525 restricted shares on June 10, 2027, or the 2027 annual meeting date.
Key Dates
| Date | Description |
|---|---|
| 06/10/2026 | Date of the restricted stock grant transaction. |
| 06/12/2026 | Date of filing for the Form 4. |
| 06/10/2027 | Vesting date for the restricted shares. |
Keywords
Astrana Health, ASTH, Form 4, Insider Trading, Equity Incentive Plan, Director Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.